A Case of Community-Acquired Pneumonia Due to Legionella pneumophila Serogroup 9 Wherein Initial Treatment with Single-Dose Oral Azithromycin Appeared Useful

Japanese journal of infectious diseases

Junko Amemura-Maekawa¹  Hiroshi Nakajima²  Toru Hashimoto³  Hiroyuki Fujii³  Tadashi Ishida⁴  Akihiro Ito⁴  Yuhei Ito⁴  Hiromasa Tachibana⁵  Takuya Takaiwa⁶ 

[1] Department of Bacteriology I, National Institute of Infectious Diseases;Department of Bacteriology, Okayama Prefectural Institute for Environmental Science and Public Health;Department of Clinical Laboratory Examination, Ohara Healthcare Foundation, Kurashiki Central Hospital;Department of Respiratory Medicine, Kurashiki Central Hospital;Department of Respiratory Medicine, National Hospital Organization Minami Kyoto Hospital;Department of Respiratory Medicine, Sakai City Medical Center

关键词: Legionella pneumophila serogroup 9;    community-acquired pneumonia (CAP);    single-dose oral azithromycin;    initial treatment;   

DOI  :  10.7883/yoken.JJID.2016.548

学科分类：传染病学

来源: National Institute of Infectious Diseases

【 摘 要 】

Legionella species are important causative pathogens for severe community-acquired pneumonia (CAP). Most cases of Legionella pneumonia are due to Legionella pneumophila serogroup 1, and CAP due to L. pneumophila serogroup 9 is rare. A fourth case of CAP due to L. pneumophila serogroup 9 has been reported, and initial treatment using single-dose oral azithromycin appeared useful. Azithromycin or fluoroquinolone injection is usually recommended for the treatment of Legionella pneumonia, and no previous reports have shown the effectiveness of single-dose oral azithromycin. This case report is therefore valuable from the perspective of possible treatment for mild to moderate Legionella pneumonia using single-dose oral azithromycin.

【 授权许可】

Unknown